RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma.
about
From bytes to bedside: data integration and computational biology for translational cancer researchPhase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaOutcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine originAbsence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial.The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic reviewIntermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma.Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic reviewEfficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis.Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1.A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.Heterogeneity of kinase inhibitor resistance mechanisms in GISTDisseminated and late metastatic disease from nasal pit leiomyosarcoma after radical surgical resection. Case report of a singular presentation of a rare disease.Response to radiation therapy in adrenocortical carcinoma.Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines.Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).Editors' pick 2012.Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304
P2860
Q21145672-E2303982-229B-4A4F-BFCB-4AC32F0AF275Q33382596-F8B8260F-29D9-4D54-A115-38955953EEF1Q33523297-732D4C6E-ECAE-4412-AF41-CEF891CFF9FEQ33561602-387EB353-D65B-45CC-8717-4F2DFD87BC16Q34566213-0C808204-0660-4568-9546-6A71A895C1C0Q35544960-F1E82DF1-DE05-4658-B7E9-E1258E5F54EAQ35583734-9A7F4451-C8E2-465D-9023-8B19038BEEE5Q36174284-58D392C8-223E-4B8A-B592-795A160CBBD7Q36177866-670F8072-7723-49A0-935C-830C5324EA13Q36670260-585E75FF-1CF9-43D9-8FDD-811C36E9BC61Q36971711-1283DE75-A199-4ADD-A8F8-B033C8E78F29Q37218711-D4FF4765-C0D7-48E1-8177-9BFB58C7B42BQ38737286-658A8711-D003-4BAF-8491-717146E26A1DQ39289780-978CD6BA-FDC6-4C65-9EC9-AD9D42B50A8BQ39860995-50817866-8C6F-4B18-90AC-AA7951A071F5Q42927824-30611D99-500C-4076-9CC1-729F0AD028F7Q42976095-C372DF26-FB75-4DD3-B184-08EDE9F674AEQ43294327-D0C0480F-76DC-4E23-B604-92B3A431D962Q58790735-9D26E0BA-4464-4456-99BD-6FA6C36A2A9D
P2860
RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@en
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@nl
type
label
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@en
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@nl
prefLabel
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@en
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@nl
P2093
P1476
RECIST vs. WHO: prospective co ...... advanced soft tissue sarcoma.
@en
P2093
A Le Cesne
EORTC Soft Tissue and Bone Sarcoma Group
M Van Glabbeke
P Therasse
P304
P356
10.1016/J.EJCA.2005.04.005
P577
2005-07-01T00:00:00Z